Barclays’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-800
Closed -$105K 5231
2025
Q4
$105K Hold
800
﹤0.01% 4566
2025
Q3
$76K Hold
800
﹤0.01% 4682
2025
Q2
$76.3K Hold
800
﹤0.01% 4638
2025
Q1
$63.5K Buy
+800
New +$86.6K ﹤0.01% 4553
2024
Q1
Sell
-20,560
Closed -$2.78M 5213
2023
Q4
$2.78M Buy
+20,560
New +$2.37M ﹤0.01% 2639
2022
Q1
Sell
-5,140
Closed -$1.9M 5267
2021
Q4
$1.9M Buy
+5,140
New +$1.95M ﹤0.01% 2417
2021
Q3
Sell
-103
Closed -$47K 4867
2021
Q2
$47K Sell
103
-21,691
-100% -$8.74M ﹤0.01% 4162
2021
Q1
$8.14M Sell
21,794
-10,896
-33% -$4.44M ﹤0.01% 1179
2020
Q4
$11.8M Buy
32,690
+5,962
+22% +$1.9M 0.01% 1096
2020
Q3
$8.04M Buy
26,728
+15,831
+145% +$5.45M ﹤0.01% 1127
2020
Q2
$3.93M Sell
10,897
-33,718
-76% -$10.8M ﹤0.01% 1554
2020
Q1
$11.9M Sell
44,615
-4,215
-9% -$1.18M 0.01% 903
2019
Q4
$15.8M Sell
48,830
-55,718
-53% -$16.9M 0.01% 1084
2019
Q3
$30.9M Buy
104,548
+86,866
+491% +$25.6M 0.02% 654
2019
Q2
$6.33M Sell
17,682
-5,756
-25% -$1.82M ﹤0.01% 1652
2019
Q1
$7.08M Sell
23,438
-19,430
-45% -$5.67M ﹤0.01% 1433
2018
Q4
$12.5M Buy
42,868
+23,028
+116% +$7.13M 0.01% 1022
2018
Q3
$7.08M Buy
19,840
+616
+3% +$197K ﹤0.01% 1491
2018
Q2
$5.22M Buy
19,224
+1,851
+11% +$471K ﹤0.01% 1688
2018
Q1
$4M Sell
17,373
-57,774
-77% -$13.2M ﹤0.01% 1815
2017
Q4
$16M Buy
75,147
+46,260
+160% +$9.52M 0.01% 931
2017
Q3
$5.6M Sell
28,887
-17,681
-38% -$3.29M 0.01% 1450
2017
Q2
$7.86M Buy
46,568
+17,270
+59% +$2.99M 0.01% 1138
2017
Q1
$4.86M Sell
29,298
-503,206
-94% -$79.3M 0.01% 1347
2016
Q4
$66.3M Buy
532,504
+503,412
+1,730% +$67.8M 0.07% 218
2016
Q3
$5.14M Buy
29,092
+3,495
+14% +$559K 0.01% 1270
2016
Q2
$3.5M Sell
25,597
-52,428
-67% -$7.45M ﹤0.01% 1571
2016
Q1
$12.3M Buy
78,025
+19,532
+33% +$2.99M 0.02% 672
2015
Q4
$10.9M Buy
58,493
+6,785
+13% +$1.1M 0.01% 848
2015
Q3
$8.8M Sell
51,708
-74,839
-59% -$15.1M 0.01% 1013
2015
Q2
$26.8M Sell
126,547
-13,569
-10% -$2.65M 0.03% 513
2015
Q1
$25.2M Buy
140,116
+81,006
+137% +$15.3M 0.03% 574
2014
Q4
$10.6M Sell
59,110
-7,093
-11% -$1.25M 0.01% 1143
2014
Q3
$10.5M Buy
66,203
+18,915
+40% +$3.16M 0.01% 1147
2014
Q2
$8.19M Buy
47,288
+17,065
+56% +$2.55M 0.01% 1314
2014
Q1
$4.35M Sell
30,223
-139,500
-82% -$20.5M ﹤0.01% 1809
2013
Q4
$18.2M Sell
169,723
-17,373
-9% -$1.59M 0.02% 817
2013
Q3
$14.6M Buy
187,096
+97,249
+108% +$7.44M 0.02% 883
2013
Q2
$6.54M Buy
+89,847
New +$5.75M 0.01% 1401

Other funds holding ILMN

Barclays's ILMN Position: Q1 2026 in Review

Barclays reduced its Illumina (ILMN) stake by 26% in Q1 2026, selling an estimated $6.68M and leaving 148,431 shares worth $18.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

Barclays first reported a position in ILMN in Q2 2013 and has held it in 52 quarters since. The position peaked at $243M in Q3 2023. 844 funds tracked by Wall St. Rank hold ILMN as of Q1 2026.

  • Barclays held 148,431 shares of Illumina worth $18.3M as of Q1 2026.
  • Barclays sold 50,871 Illumina shares in Q1 2026, an estimated $6.68M.
  • Illumina made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1141 holding.
  • Barclays first reported a position in Illumina in Q2 2013 and has held it in 52 quarters since.
  • Barclays's Illumina position peaked at $243M in Q3 2023.
  • 844 funds tracked by Wall St. Rank held Illumina as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.